CD22
Basic information
Region (hg38): 19:35319261-35347361
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD22 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 45 | 54 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 46 | 8 | 4 |
Variants in CD22
This is a list of pathogenic ClinVar variants found in the CD22 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-35332053-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
19-35332604-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
19-35332629-C-T | Likely benign (Feb 01, 2023) | |||
19-35332649-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
19-35332718-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
19-35332786-G-A | not specified | Uncertain significance (Oct 25, 2024) | ||
19-35332801-G-T | not specified | Uncertain significance (Nov 29, 2021) | ||
19-35332900-G-A | not specified | Uncertain significance (Jun 25, 2024) | ||
19-35336068-C-T | not specified | Uncertain significance (Apr 28, 2023) | ||
19-35336078-A-G | not specified | Likely benign (Jun 09, 2022) | ||
19-35336135-C-T | not specified | Uncertain significance (Feb 09, 2022) | ||
19-35336188-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
19-35336192-C-T | not specified | Likely benign (Mar 07, 2023) | ||
19-35336228-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
19-35336229-C-A | not specified | Uncertain significance (Mar 07, 2024) | ||
19-35336236-A-C | not specified | Uncertain significance (Nov 09, 2022) | ||
19-35336272-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
19-35336279-G-T | not specified | Uncertain significance (Sep 22, 2023) | ||
19-35336323-G-C | not specified | Uncertain significance (Sep 03, 2024) | ||
19-35337812-A-G | not specified | Uncertain significance (Dec 04, 2024) | ||
19-35337814-T-C | not specified | Uncertain significance (Dec 04, 2024) | ||
19-35337831-C-T | Benign (Mar 29, 2018) | |||
19-35337832-G-A | not specified | Likely benign (Jun 07, 2023) | ||
19-35337835-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
19-35337923-T-A | not specified | Uncertain significance (Jan 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD22 | protein_coding | protein_coding | ENST00000085219 | 13 | 28095 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.804 | 0.196 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.674 | 445 | 487 | 0.914 | 0.0000278 | 5555 |
Missense in Polyphen | 95 | 131.83 | 0.72064 | 1552 | ||
Synonymous | -0.332 | 214 | 208 | 1.03 | 0.0000136 | 1630 |
Loss of Function | 4.97 | 9 | 45.0 | 0.200 | 0.00000255 | 445 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000928 | 0.0000924 |
European (Non-Finnish) | 0.0000972 | 0.0000967 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);B cell receptor signaling pathway - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);B Cell Receptor Signaling Pathway;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;CD22 mediated BCR regulation;BCR;BCR signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.282
Intolerance Scores
- loftool
- 0.238
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 19.95
Haploinsufficiency Scores
- pHI
- 0.368
- hipred
- N
- hipred_score
- 0.371
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.402
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd22
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- cell adhesion;regulation of endocytosis;regulation of B cell proliferation;regulation of immune response;negative regulation of calcium-mediated signaling;negative regulation of B cell receptor signaling pathway;negative regulation of immunoglobulin secretion
- Cellular component
- cytoplasm;early endosome;plasma membrane;cell surface;integral component of membrane;neuronal cell body membrane;recycling endosome;extracellular exosome
- Molecular function
- IgM binding;signaling receptor binding;protein binding;protein phosphatase binding;carbohydrate binding;sialic acid binding;CD4 receptor binding